Inflammatory Markers in Preeclampsia

NCT01385813 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2011-07-18

No results posted yet for this study

Summary

This is an investigation of inflammatory markers in women destined to develop preeclampsia.

Conditions

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-01-31
Primary Completion
2004-05-31
Completion
2004-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01385813 on ClinicalTrials.gov